Sabin Vaccine Institute Appoints Filip Dubovsky to Board of Trustees
17 oct. 2019 10h00 HE
|
The Sabin Vaccine Institute
Washington, D.C., Oct. 17, 2019 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that Dr. Filip Dubovsky, head of clinical engagement and policy at AstraZeneca, has joined its...
INNATE PHARMA PRÉSENTE DES RESULTATS CLINIQUES PRELIMINAIRES SUR IPH5401 ET MONALIZUMAB AU CONGRÈS DE L’ESMO 2019
01 oct. 2019 01h00 HE
|
INNATE PHARMA
Profil de sécurité gérable de la combinaison d’IPH5401 avec durvalumab dans l’étude en escalade de dose STELLAR-001 dans des tumeurs solides avancées Deux extensions de cohorte ont démarré : dans...
Innate Pharma presents early clinical data on IPH5401 and monalizumab at the ESMO 2019 congress
01 oct. 2019 01h00 HE
|
INNATE PHARMA
IPH5401 dose-escalation study in combination with durvalumab in advanced solid tumors, STELLAR-001, shows manageable safety profile Initiation of two expansion cohorts in non-small cell lung cancer...
Lung Ambition Alliance unveils new initiatives to address lung cancer survival at the World Conference on Lung Cancer
07 sept. 2019 10h00 HE
|
Lung Ambition Alliance
New grants program to support local initiatives driven by patient organizations that have the potential to transform patient care Series of interactive and educational exhibits at the congress to...
BioCardia Signs Exclusive Development Agreement With AstraZeneca
25 juil. 2019 06h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
Hudson RPO and AstraZeneca win HRD magazine’s Innovative HR Team award
18 mars 2019 09h00 HE
|
Hudson Global, Inc.
SYDNEY, Australia, March 18, 2019 (GLOBE NEWSWIRE) -- Hudson RPO, along with its client, AstraZeneca Australia have been named Innovative HR Team winner by HRD magazine. The award recognises the...
Predictive Technology Group Appoints Dr. Gregory A. Prince to Its Scientific Advisory Board
17 janv. 2018 09h20 HE
|
PREDICTIVE TECHNOLOGY GROUP, INC.
SALT LAKE CITY, Jan. 17, 2018 (GLOBE NEWSWIRE) --
Predictive Technology Group, Inc. (OTC PINK:PRED), a leader in the use of data analytics for disease identification and subsequent...
Peregrine Pharmaceuticals Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2016 and Recent Developments
14 juil. 2016 16h05 HE
|
Peregrine Pharmaceuticals Inc.
-- Avid Contract Manufacturing Revenues Increased 66% to $44.4 Million with a Revenue Backlog of $68 Million Heading into Fiscal Year 2017 ---- Growing Biomanufacturing Demand Prompts Plans for Third...
FEI Partners with Five Pharmaceutical Companies, the Medical Research Council and the University of Cambridge to form Cryo-EM Research Consortium
04 avr. 2016 06h05 HE
|
FEI Company
HILLSBORO, Ore. and LONDON, April 04, 2016 (GLOBE NEWSWIRE) -- FEI (NASDAQ:FEIC) has partnered with five pharmaceutical companies: Astex Pharmaceuticals, AstraZeneca, GlaxoSmithKline, Heptares...
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
07 mars 2016 16h05 HE
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., March 07, 2016 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend...